BioRestorative Therapies, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | 99.7% | -21,414.0% | -23,755.4% |
| FY2017 | 100.0% | -10,338.6% | -11,660.1% |
| FY2018 | — | -6,889.8% | -11,277.3% |
| FY2019 | — | -6,486.2% | -11,267.6% |
| FY2020 | — | -3,574.1% | -14,639.9% |
| FY2021 | — | -57,191.0% | -96,311.5% |
| FY2022 | — | -15,838.1% | -11,037.0% |
| FY2023 | 100.0% | -10,439.5% | -7,145.2% |
| FY2024 | 93.0% | -2,881.6% | -2,239.2% |
| FY2025 | 93.4% | -4,350.1% | -3,959.4% |